Dark Streaming/Mobile Old Site Home Daily Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:18:21 EDT Sat 01 Apr 2023
Enter Symbol
or Name
USA
CA



News for C:PSYB from 2022-04-01 to 2023-03-31 - 25 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2023-01-18 20:19C:PSYBPsybio Therapeutics Corp0.10Private PlacementPsybio Therapeutics 18,199,747-share private placement
2023-01-13 18:13C:PSYBPsybio Therapeutics Corp0.07News ReleasePsybio closes $276,689 second tranche private placement
2023-01-10 13:00C:PSYBPsybio Therapeutics Corp0.08News ReleasePsybio Therapeutics appoints Wisenberg as director
2023-01-05 10:41C:PSYBPsybio Therapeutics CorpNews ReleasePsybio completes $633,281 1st tranche of financing
2022-12-08 10:05C:PSYBPsybio Therapeutics Corp0.08News ReleasePsybio files three U.S. patent applications
2022-12-06 12:08C:PSYBPsybio Therapeutics Corp0.065News ReleasePsybio files four U.S. PCT patent applications
2022-12-01 12:12C:PSYBPsybio Therapeutics Corp0.07News ReleasePsybio Therapeutics arranges $1M private placement
2022-11-29 13:04C:PSYBPsybio Therapeutics Corp0.06News ReleasePsybio files Q3 2022 results, talks patent filings
2022-11-29 09:12C:PSYBPsybio Therapeutics Corp0.06SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-11-29 09:12C:PSYBPsybio Therapeutics Corp0.06SEDAR MD & ASEDAR MD & A
2022-10-11 10:30C:PSYBPsybio Therapeutics Corp0.125News ReleasePsybio reaches agreement for psilocybin clinical trial
2022-09-19 11:43C:PSYBPsybio Therapeutics CorpNews ReleasePsybio receives patent application acceptance
2022-08-29 10:08C:PSYBPsybio Therapeutics Corp0.15SEDAR MD & ASEDAR MD & A
2022-08-29 08:51C:PSYBPsybio Therapeutics Corp0.15SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-08-11 17:02C:PSYBPsybio Therapeutics Corp0.085News ReleasePsybio Therapeutics files data for patent conversion
2022-08-08 12:45C:PSYBPsybio Therapeutics CorpNews ReleasePsybio Therapeutics applies for international patents
2022-06-27 17:27C:PSYBPsybio Therapeutics Corp0.12News ReleasePsybio shareholders to vote on share rollback Aug. 11
2022-06-02 11:56C:PSYBPsybio Therapeutics Corp0.07News ReleasePsybio begins process development of manufacturing tech
2022-05-30 11:20C:PSYBPsybio Therapeutics Corp0.07News ReleasePsybio files Q1 financials; talks 2022 clinic results
2022-05-30 07:34C:PSYBPsybio Therapeutics Corp0.07SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-05-30 07:34C:PSYBPsybio Therapeutics Corp0.07SEDAR MD & ASEDAR MD & A
2022-05-16 10:19C:PSYBPsybio Therapeutics Corp0.07News ReleasePsybio develops purification method for compound
2022-05-06 09:48C:PSYBPsybio Therapeutics Corp0.09News ReleasePsybio begins blood-brain barrier permeability testing
2022-04-27 11:35C:PSYBPsybio Therapeutics Corp0.10News ReleasePsybio applies to convert provisional patents to full
2022-04-13 11:46C:PSYBPsybio Therapeutics Corp0.09News ReleasePsybio begins picking investigators for clinical trials